본문 바로가기
KERD
논문KCI 등재

Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: Adjuvant radiotherapy (RT) has been performed to reduce locoregional failure (LRF) following radical cystectomy for locally advanced bladder cancer; however, its efficacy has not been well established. We analyzed the locoregional recurrence patterns of post-radical cystectomy to identify patients who could benefit from adjuvant RT and determine the optimal target volume. Materials and Methods: We retrospectively reviewed 160 patients with stage ≥ pT3 bladder cancer who were treated with radical cystectomy between January 2006 and December 2015. The impact of pathologic findings, including the stage, lympho-vascular invasion, perineural invasion, margin status, nodal involvement, and the number of nodes removed on failure patterns, was assessed. Results: Median follow-up period was 27.7 months. LRF was observed in 55 patients (34.3%), 12 of whom presented with synchronous local and regional failures as the first failure. The most common failure pattern was distant metastasis (40%). Among LRFs, the most common recurrence site was the cystectomy bed (15.6%). Patients with positive resection margins had a significantly higher recurrence rate compared to those without (28% vs. 10%, p=0.004). The pelvic nodal recurrence rate was < 5% in pN0 patients; the rate of recurrence in the external and common iliac nodes was 12.5% in pN+ patients. The rate of recurrence in the common iliac nodes was significantly higher in pN2–3 patients than in pN0–1 patients (15.2% vs. 4.4%, p=0.04). Conclusion: Pelvic RT could be beneficial especially for those with positive resection margins or nodal involvement after radical cystectomy. Radiation fields should be optimized based on the patient-specific risk factors.

Abstract

Purpose: Adjuvant radiotherapy (RT) has been performed to reduce locoregional failure (LRF) following radical cystectomy for locally advanced bladder cancer; however, its efficacy has not been well established. We analyzed the locoregional recurrence patterns of post-radical cystectomy to identify patients who could benefit from adjuvant RT and determine the optimal target volume. Materials and Methods: We retrospectively reviewed 160 patients with stage ≥ pT3 bladder cancer who were treated with radical cystectomy between January 2006 and December 2015. The impact of pathologic findings, including the stage, lympho-vascular invasion, perineural invasion, margin status, nodal involvement, and the number of nodes removed on failure patterns, was assessed. Results: Median follow-up period was 27.7 months. LRF was observed in 55 patients (34.3%), 12 of whom presented with synchronous local and regional failures as the first failure. The most common failure pattern was distant metastasis (40%). Among LRFs, the most common recurrence site was the cystectomy bed (15.6%). Patients with positive resection margins had a significantly higher recurrence rate compared to those without (28% vs. 10%, p=0.004). The pelvic nodal recurrence rate was < 5% in pN0 patients; the rate of recurrence in the external and common iliac nodes was 12.5% in pN+ patients. The rate of recurrence in the common iliac nodes was significantly higher in pN2–3 patients than in pN0–1 patients (15.2% vs. 4.4%, p=0.04). Conclusion: Pelvic RT could be beneficial especially for those with positive resection margins or nodal involvement after radical cystectomy. Radiation fields should be optimized based on the patient-specific risk factors.

참고문헌 (24)

  1. Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
  2. 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017", Cancer Research and Treatment, 52(2), pp.335~350 (2020), 대한암학회
  3. Grossman HB, "Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer", N Engl J Med, 349, pp.859~866 (2003)
  4. Herr HW, "Surgical factors influence bladder cancer outcomes : a cooperative group report", J Clin Oncol, 22, pp.2781~2789 (2004)
  5. Zehnder P, "Unaltered oncological outcomes of radical cystectomy with extended lymphadenectomy over three decades", BJU Int, 112, pp.E51~8 (2013)
  6. Shariat SF, "Outcomes of radical cystectomy for transitional cell carcinoma of the bladder : a contemporary series from the Bladder Cancer Research Consortium", J Urol, 176(6 Pt 1), pp.2414~2422 (2006)
  7. Honma I, "Local recurrence after radical cystectomy for invasive bladder cancer : an analysis of predictive factors", Urology, 64, pp.744~748 (2004)
  8. Fischer-Valuck BW, "Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer", Cancer Med, 8, pp.3698~3709 (2019)
  9. Zaghloul MS, "Postoperative radiotherapy of carcinoma in bilharzial bladder : improved disease free survival through improving local control", Int J Radiat Oncol Biol Phys, 23, pp.511~517 (1992)
  10. Magers MJ, "Staging of bladder cancer", Histopathology, 74, pp.112~134 (2019)
  11. Bi L, "Extended vs nonextended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer : a systematic review and meta-analysis of comparative studies", BJU Int, 113, pp.E39~48 (2014)
  12. Reddy AV, "Patterns of failure after radical cystectomy for pT3-4 bladder cancer : implications for adjuvant radiation therapy", Int J Radiat Oncol Biol Phys, 94, pp.1031~1039 (2016)
  13. Baumann BC, "Bladder cancer patterns of pelvic failure : implications for adjuvant radiation therapy", Int J Radiat Oncol Biol Phys, 85, pp.363~369 (2013)
  14. Baumann BC, "A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy", Int J Radiat Oncol Biol Phys, 85, pp.81~88 (2013)
  15. Ku JH, "Risk prediction models of locoregional failure after radical cystectomy for urothelial carcinoma : external validation in a cohort of Korean patients", Int J Radiat Oncol Biol Phys, 89, pp.1032~1037 (2014)
  16. Novotny V, "Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder", World J Urol, 33, pp.1753~1761 (2015)
  17. Neuzillet Y, "Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle : results from a nationwide case-control study", BJU Int, 111, pp.1253~1260 (2013)
  18. Christodouleas JP, "Optimizing bladder cancer locoregional failure risk stratification after radical cystectomy using SWOG 8710", Cancer, 120, pp.1272~1280 (2014)
  19. Zaghloul MS, "Postoperative radiotherapy of carcinoma in bilharzial bladder using a three-fractions per day regimen", Radiother Oncol, 6, pp.257~265 (1986)
  20. Necchi A, "Development of a prediction tool for exclusive locoregional recurrence after radical cystectomy in patients with muscle-invasive bladder cancer", Clin Genitourin Cancer, 17, pp.7~14 (2019)
  21. Reisinger SA, "Combined pre-and postoperative adjuvant radiation therapy for bladder cancer--a ten year experience", Int J Radiat Oncol Biol Phys, 24, pp.463~468 (1992)
  22. Spera JA, "A comparison of preoperative radiotherapy regimens for bladder carcinoma. The University of Pennsylvania experience", Cancer, 61, pp.255~262 (1988)
  23. Orré M, "Adjuvant radiotherapy after radical cystectomy for muscleinvasive bladder cancer : A retrospective multicenter study", PLoS One, 12, pp.e0174978~ (2017)
  24. Zaghloul MS, "Adjuvant sandwich chemotherapy plus radiotherapy vs adjuvant chemotherapy alone for locally advanced bladder cancer after radical cystectomy : a randomized phase 2 trial", JAMA Surg, 153, pp.e174591~ (2018)

관련 논문AI추천

The Prognosis and the Role of Adjuvant Chemotherapy for Node-Positive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by Surgery김좌훈, 김형돈, 박계진, 윤신교, 이용준, 이재련, 정혜현, 홍범식대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호Neoadjuvant Cisplatin-Based Chemotherapy Followed by Selective Bladder Preservation Chemoradiotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder: Post Hoc Analysis of Two Prospective Studies박원, 송완, 권기영, 김찬교, 박세훈, 성현환, 임성희, 정병창, 정재훈, 조성욱, 표홍렬대한암학회 · Cancer Research and Treatment2024 · 제56권 제3호The Characteristics of Recurrent Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy without Bladder Cuff Excision곽철, 강민용, 구자현, 김현회, 정창욱연세대학교의과대학 · Yonsei Medical Journal2015 · 제56권 제2호Clinical Prognostic Factors for Radical Cystectomy in Bladder Cancer장성구, 전성현, 전승현대한암학회 · Cancer Research and Treatment2005 · 제37권 제1호Risk Factors and Patterns of Locoregional Recurrence After Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma박원, 강민용, 권기영, 김찬교, 박병관, 박성윤, 서성일, 유규상, 이현무, 전성수, 전황균, 정병창, 최한용, 표홍렬대한암학회 · Cancer Research and Treatment2022 · 제54권 제1호Neoadjuvant Chemotherapy-Guided Bladder-Sparing Treatment for Muscle-Invasive Bladder Cancer: Results of a Pilot Phase II StudyAiping Zhou, Changling Li, Chuanzhen Cao, Dong Wang, Hongsong Bai, Hongzhe Shi, Jianhui Ma, Jianzhong Shou, Jin Zhang, Jun Tian, Kaopeng Guan, Linjun Hu, Shan Zheng, Weixing Jiang, Wen Zhang, Xiaoli Feng, Xingang Bi, Yan Chen, Yexiong Li, Youyan Guan, Yueping Liu, Zejun Xiao, Zhilong Hu대한암학회 · Cancer Research and Treatment2021 · 제53권 제4호

이 간행물의 다른 논문 (9건)